Introduction
The clinical demand for a device to monitor Blood Pressure (BP) in ambulatory scenarios with minimal use of inflation cuffs is increasing. Based on the so-called Pulse Wave Velocity (PWV) principle, this abstract summarizes the results of a long-term study involving a novel concept of BP monitor that can be fully integrated within a chest sensor. After a preliminary calibration, the sensor provides non-occlusive beat-by-beat estimations of Mean Arterial Pressure (MAP) by measuring the Pulse Transit Time (PTT) of arterial pressure pulses travelling from the ascending aorta towards the subcutaneous vasculature of the chest. A full description of the presented study is provided in [4] .
Methods
A wearable system to monitor the PWV of central arteries was already reported in [1] and [2] . So-called chest sensor, the technique relies on the estimation of the Pulse Transit Time (PTT) of pressure pulses travelling from the aortic valve towards the cutaneous vasculature on the sternum. Figure 1 summarizes the working principle of the sensor. A full description of the implemented technologies is provided in [3] and [4] . 
Results
In a cohort of 15 healthy male subjects, a total of 462 simultaneous readings consisting of reference MAP and chest PTT were acquired. Each subject was recorded at three different days: D, D+3 and D+14. Overall, the implemented protocol induced MAP values to range from 80 ± 6 mmHg in baseline, to 107 ± 9 mmHg during isometric handgrip maneuvers (see Figure 2) . Different calibration strategies were tested in order to map chest PTT (in ms) to MAP values (in mmHg). A description of the studied strategies is provided by [4] . Agreement between reference and chest-sensor MAP values was tested by using Bland-Altman analysis (mean error = 0.7 mmHg, standard deviation = 5.1 mmHg) as depicted by Figure 3 . The cumulative percentage of MAP values provided by the chest sensor falling within a range of ±5 mmHg compared to reference MAP readings was of 70%, within ±10 mmHg was of 91%, and within ±15mmHg was of 98%. These results point at the fact that the chest sensor complies with the British Hypertension Society (BHS) requirements of Grade A BP monitors, when applied to MAP readings. Grade A performance was maintained even two weeks after having performed the initial subject-dependent calibration. Figure 4 illustrates three examples of subject-dependent performance of the novel chest BP sensor. 
Conclusions
In conclusion, this paper introduces a sensor and a calibration strategy to perform MAP measurements at the chest. The encouraging performance of the presented technique paves the way towards an ambulatory-compliant, continuous and non-occlusive BP monitoring system.
